Carl Zeiss Meditec AG
AFX: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€46.00 | Bnqwtyg | Jkyksmkn |
Carl Zeiss: Raising FVE 18% After Assigning a More Favorable Outlook and Reviewing Balance Sheet
After reviewing our key valuation assumptions, we are raising our fair value estimate for Carl Zeiss Meditec to EUR 90 from EUR 76, driven by our updated outlook of its long-term potentials, combined with a higher level of appreciation for the company’s cash balance. Zeiss is one of the largest medical technology companies in the world and it operates in two segments: ophthalmic devices and microsurgery.